Literature DB >> 34007304

Potential Genes Associated with the Survival of Lung Adenocarcinoma Were Identified by Methylation.

Ziyuan Shen1, Chenlu He1, Haimiao Chen1, Lishun Xiao1,2, Yingliang Jin1,2, Shuiping Huang1,2.   

Abstract

BACKGROUND: Lung adenocarcinoma (LUAD) is the most common pathological type of lung cancer. The purpose of this study is to search for genes related to the prognosis of LUAD through methylation based on a linear mixed model (LMM).
METHODS: Gene expression, methylation, and survival data of LUAD patients were downloaded from the TCGA database. Based on the LMM model, the GEMMA algorithm was used to screen the predictive genes related to LUAD survival. The Cox model was used to further screen the predicted genes, and then, protein-protein interaction (PPI) network was constructed. Through the software plugin Cytoscape MCODE 3.8.0, the most closely related genes in the PPI network module were selected for in-depth biological function analysis to further explore the interaction and correlation between genes.
RESULTS: We screened out 97 predictive genes from 18,834 genes and eliminated one gene associated with lung squamous cell carcinoma from previous studies, leaving 96 genes. The MCODE and the Kaplan-Meier curve analysis were used to finally identify two genes ASB16 and NEDD4 that are related to the prognosis of LUAD.
CONCLUSIONS: The newly identified two genes associated with the prognosis of LUAD may provide a basis for the treatment of patients.
Copyright © 2020 Ziyuan Shen et al.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 34007304      PMCID: PMC8108640          DOI: 10.1155/2020/7103412

Source DB:  PubMed          Journal:  Comput Math Methods Med        ISSN: 1748-670X            Impact factor:   2.238


1. Introduction

Global cancer data show that the incidence and mortality rates of lung cancer again top the list [1]. Approximately 520,000 new cases are reported annually in men and 267,000 in women. Nearly 61% of the pathological subtypes of lung cancer are lung adenocarcinoma (LUAD), and lung cancer poses a serious threat to human health [2]. Pathologically, different types of cancer cells originate from different sites in the lung. LUAD refers to the mucus-secreting epithelial cells that originate from the smaller bronchial mucosa, so most adenocarcinomas are located in the peripheral part of the lung in a spherical mass close to the pleura. Unlike squamous cell lung cancer, LUAD is more likely to occur in women and nonsmokers [3]. However, smoking remains a major environmental risk factor for lung cancer [4]. Causes of high mortality from LUAD include the lack of sensitive and specific early biomarkers, high likelihood of drug resistance, and metastasis [5]. In recent years, some prognostic genes related to LUAD have been found, which provide an effective criterion for early molecular diagnosis of LUAD and greatly promote the treatment of patients. The survival rate of lung cancer is on the rise gradually. In China, the 5-year relative survival rate is about 40.5%. That is up about 10 percent from a decade ago. In this study, the new predictive gene screening model and bioinformatics analysis are used to identify the driver genes associated with LUAD survival and to provide an effective criterion for early molecular diagnosis of LUAD. Traditional treatments for LUAD usually include surgery, chemotherapy, radiation therapy, and targeted therapy [6]. In the past few years, the research on LUAD has been focused on molecular targeted therapy, controlling the metastasis of LUAD cells, and identifying the target genes [7] regulated by LUAD stem cells. In previous studies, SNP was mainly used to predict gene expression, and it has a good performance in predicting gene expression. Previous studies have shown that genes associated with LUAD survival are concentrated in regions such as 5p15.33 and 15q. Methylation was used to predict gene expression in order to obtain methylation-driven genes associated with LUAD prognosis. DNA methylation is one of the core elements of epigenetic modification and an important signal transduction tool for regulating genome function [4]. In addition, the change of methylation state is an important factor leading to tumor genesis, including the decrease of the methylation level in the whole genome and the abnormal increase of the local methylation level in the CpG island, which leads to the instability of the genome and the nonexpression of tumor suppressor genes. Therefore, methylation can provide an important basis for early diagnosis and prognosis of cancer and provide a new idea for further clinical application. TCGA is the cancer and tumor gene mapping project initiated by the United States in 2005. The purpose of the project is to study the genome changes in cancer by using genome analysis technology. A large-scale genome sequencing has been done, including more than 30 kinds of cancers. TCGA has laid a foundation for the classification and in-depth study of the molecular pathogenesis of LUAD [8]. To search for genes associated with the prognosis of LUAD, we used an open cancer genome atlas database The Cancer Genome Atlas (TCGA) to obtain genetic and epigenetic data on LUAD [9]. LMM is a multigene model because it assumes that all mutations have a nonzero effect on gene expression. We used the effective GEMMA algorithm to fit the LMM using the limited maximum likelihood method. The gene expression value was predicted by methylation, and predictive genes were screened (defined as genes with R2 ≥ 0.05) [10]. The COX model was used to further screen the predictive genes to obtain the genes related to the prognosis of LUAD and to identify the relationship between methylation drive and LUAD. Protein-protein interaction network analysis was performed on these genes to understand the role of methylation in the development and progression of LUAD. The core genes with the highest scores in the highest clusters were extracted by MCODE in Cytoscape software. GO enrichment analysis was performed on the core genes, and Kaplan-Meier curve analysis was drawn.

2. Methods and Materials

2.1. Data Processing and Analysis

Gene expression, methylation, and clinical data of LUAD were obtained from UCSC Xena (https://xenabrowser.net/). Samples soaked in formalin-fixed paraffin-embedded tissues were excluded. Quantile conversion was performed by using the qqnorm function in R software. The original gene expression data included 20,530 genes and 515 samples, and the methylation data came from 458 samples. Firstly, quality control was carried out on the gene expression data, and more than 50% of the zero expression was eliminated. DNA methylation levels in a group of 500 kb genes were then filtered by combining gene expression levels with DNA methylation levels. Combining the gene expression and methylation data according to the sample name, 18,834 genes and 450 samples were obtained. A total of 450 samples were included in our analysis, and the clinical variables included age, gender, and annual smoking volume. For details, basic clinical information of patients with LUAD were summarized in Table 1. The missing values were replaced by the median.
Table 1

Basic clinical information of patients with LUAD.

Clinical parametersNumber of cases
Age (years)
 >67193
 ≤67257
Sex
 Male209
 Female241
Number-pack-years-smoked
 >37151
 ≤37299

2.2. Two-Step Identification of Genes Associated with the Prognosis of LUAD

2.2.1. Predictive Genes Were Identified Using LMM

We bring the data into the linear mixed model. Let us first assume that all the markers are normalized to mean 0 and variance 1. Let E be an n-vector of the expression level of the ith gene measured on n individuals, L is the n × p matrix of DNA methylation. The simple linear model that relates DNA methylation to gene expression level is E = Lc, where c is the p-vector effect value corresponding to the ith gene. The square correlation coefficient (R2) of the predicted value is used to measure the performance. The predicted gene expression values can be regarded as the potential effect of DNA methylation. The R2 ≥ 0.05 gene is thought to be methylation driven, and these genes are retained for further analysis.

2.2.2. Cox Regression Analysis Identified the Prognostic Genes

The Cox regression model was used to further analyze the predictive genes screened by the linear mixed model and to explore the relationship between methylation-driven genes and the prognosis of LUAD [36]. It is still assumed that all the markers may be involved in the development of LUAD, and the effect size of each gene should follow a normal distribution: where h0(t) is the arbitrary baseline risk function corresponding to the reference level of the covariates, and β is the effect size of gene i, and γ = (γ1, γ2, ⋯, γ) is the m-dimensional vector of the random effect size of DNA methylation; σ2 is the variance of DNA methylation. We used the false discovery method to adjust the p value results (FDR < 0.01).

2.3. Protein-Protein Interaction Network and Module Analysis

In order to mine the core regulatory genes, we constructed the protein interaction network by using the STRING database (version 11.0). We also implemented signaling pathways for these genes through Cytoscape software (version 3.8.0) and visualized them through CluePedia. Through the MCODE plugin of Cytoscape software, the most closely connected modules were selected from the constructed PPI network for in-depth biological function analysis [37]. The genes contained in the modules are the core genes.

2.4. Kaplan-Meier Curve Analysis

Kaplan-Meier curve analysis was used to analyze the correlation between core genes and survival. We used the original expression values of genes and the predicted expression values of methylation to calculate their effects on survival, respectively. The prognosis genes were screened with p < 0.05 as statistically significant difference.

2.5. Gene Set Enrichment Analysis (GSEA)

In order to analyze the biological characteristics of prognosis genes and their roles in the development of LUAD, the prognosis genes selected by Kaplan-Meier Curve analysis were analyzed by gene set enrichment analysis. GSEA package, clusterProfiler package, and GSEA function were used in R software to obtain the enrichment results of KEGG pathway and GO pathway, respectively. The number of permutations was set to 1,000, and a falsediscoveryrate(FDR) < 0.25 was recognized as statistically significant.

3. Results

3.1. Description of Previous Studies

Before October 2019, we searched the GWAS directory with “lung cancer, lung adenocarcinoma” as the search term and conducted a systematic literature search on EBI to preliminarily understand the previous research achievements of LUAD pathogenic genes. A total of 26 articles were included, and these studies were mainly carried out in European populations. Details of the 26 articles we have included are shown in Table 2 and Figure 1, published from 2008 to 2019. A total of 314 genes were reported. The genes associated with LUAD survival were mainly located in 5p15.33, 6p21.3, 15q25, and 17q24.3. By analyzing the GO and KEGG pathways of genes related to LUAD in GWAS, the results showed that gene enrichment molecule functions were mainly identical protein binding, and the biological processes were mainly positive regulation of transcription from RNA polymerase II promoters, and the components mainly included integral component of membrane. There were altogether 22 pathways in KEGG. Several articles confirmed that genes TP63, TERT, and CLPTM1L were related to the prognosis of LUAD.
Table 2

Abstracts of articles related to LUAD.

PMIDYear N (case/control)POPGenesRef
1838567620081,154/1,137European6[11]
1838573820081,989/2,625European5[12]
187808722008194/219European5[13]
1897878720085,095/5,200European3[14]
1897879020083,259/4,159European2[15]
1965430320091.952/1,438European4[16]
1983600820095,739/5,848European7[17]
203047032010328/407European1[18]
207004382010584/585East Asian2[19]
2087159720101,004/1,900Japanese2[20]
2087661420101,425/3,011Korean1[21].
2172530820112,331/3,077Han Chinese4[22]
218663432011426/497Korean3[23]
2279772420121,695/5,333Japanese4[24]
22899653201214.900/29,485European1[25]
2314360120125,510/4,544East Asian9[26]
2432591420132,331/3,077Han Chinese4[27]
2465828320142,383/3,160Han Chinese5[28]
24880342201411,348/15,361European4[29]
251455022014354Han Chinese1[30]
2739350420161,737/3,605African American6[31]
275017812016663/4,367Japanese6[32]
28604730201711,273/55,483European208[33]
299243162018775/31,563European18[34]
3010456720184,972/5,501European1[35]
31326317201927,120/27,355Han Chinese3[4]

N: initial sample size; POP: population ethnicity.

Figure 1

(a) Circular Manhattan diagram of all reported SNPs in GWAS. (b) The number of reported SNPs within 1 Mb window size in GWAS. (c) The most frequently reported genes in these articles.

3.2. Results of Linear Mixed Model and Cox Regression Model

After placing 18,834 genes into a linear mixed model, we measured their performance by using the predicted square correlation coefficient (R2). The results showed that there were 18,495 genes with R2 greater than or equal to 0.5. Table 3 showed information about the ten genes with a higher R2 value. A total of 114 prognostic genes were screened by Cox regression model to eliminate the nonprotein-coding genes. Finally, 97 prognostic genes were obtained. After searching on EBI, we excluded DTNBP1, which was linked to lung squamous cell carcinoma in previous studies [38]. In addition, we have identified a smoking-related gene, ASB18, which may further influence the development of lung cancer [39].
Table 3

Correlation R2 values for top ten genes.

GeneCHR R 2 GeneCHR R 2
FLJ42875 10.904 FBXL16 160.917
LOC441869 10.931 MSLN 160.952
KCNQ1 110.940 H3F3B 170.923
MUC5B 110.903 ZNF750 170.918
CBFA2T3 160.904 ADAMTSL5 190.913

3.3. Protein-Protein Interaction Network and Selection of Core Genes

In this study, the protein interaction network was built by using the STRING database (version 11.0). We put 96 genes into STRING, and the species chooses to be Homo sapiens. The PPI score parameter is set at 0.400 (indicating moderate confidence). The network contains 96 nodes and37 edges, and we hide the unconnected nodes in the network. It is worth noting that there is a strong association between the genes of ASB16, ASB18, MYLIP, NEDD4, and ZDHHC2. The result is shown in Figure 2.
Figure 2

Results of protein-protein interaction network analysis.

Links between genes are visualized through CluePedia, as shown in Figure 3. Through the MCODE plugin of Cytoscape 3.8.0 software (setting parameters as degreecut − off = 2, nodescore = 0.2, k − core = 2, and maximumdepth = 100), the most closely connected modules were selected from the constructed PPI network for in-depth biological function analysis. It was found that the genes included in the most compact modules in the cluster were NEDD4, ASB18, MYLIP, and ASB16, and the highest scoring node in the cluster was ASB16.
Figure 3

Visualize links between genes. Functionally grouped network with terms as nodes linked based on their kappa score level (≥0.3).

3.4. Kaplan-Meier Curve Analysis Results

We used Kaplan-Meier curves to describe the survival analysis of the four selected genes, and, respectively, analyzed the original gene expression data and the gene expression data predicted by methylation. The results showed that the genes of ASB16 and NEDD4 had a definite effect (p < 0.05) on the prognosis of LUAD regardless of the original value or the predictive value, while the genes of ASB18 and MYLIP had no significant effect. The specific results are shown in Figure 4.
Figure 4

Kaplan-Meier curve analysis results. (a, b) The combination of gene ASB16 expression and methylation. (c, d) The combination of gene NEDD4 expression and methylation. (e, f) The combination of gene ASB18 expression and methylation. (g, h) The combination of gene MYLIP expression and methylation. pred is the gene expression predicted by methylation.

3.5. GSEA Results

The GSEA analysis showed that the main functions of the ASB16 gene were covalent chromatin modification, histone methylation, and extracellular transport; the main enrichment pathways were taste transduction, DNA replication, and nucleotide excision repair. The main functions of the NEDD4 gene were positive regulation of multiorganism process, regulation of cytoskeleton organization, and divalent inorganic cation homeostasis; the mainly enrichment pathways were MAPK signaling pathway and pathway in cancer. The most significantly enriched signaling pathways based on their NES are shown in Table 4; partial enrichment results are shown in Figure 5.
Table 4

The most significantly enriched signaling pathways.

GeneMSigDB collectionGene set nameNES p valFDR
NEDD4c2.cp.kegg.v7.1.symbols.gmtKEGG_FOCAL_ADHESION2.6660.0020.008
KEGG_REGULATION_OF_ACTIN_CYTOSKELETON2.5230.0020.008
KEGG_ECM_RECEPTOR_INTERACTION2.5110.0020.008
c5.bp.v7.1.symbols.gmtGO_GRANULOCYTE_MIGRATION2.5620.0020.011
GO_DEFENSE_RESPONSE_TO_VIRUS2.5110.0020.011
GO_SUBSTRATE_ADHESION_DEPENDENT_CELL_SPREADING2.4620.0020.011

ASB16 c2.cp.kegg.v7.1.symbols.gmtKEGG_TASTE_TRANSDUCTION1.7010.0020.088
KEGG_ABC_TRANSPORTERS1.6050.0060.088
KEGG_LINOLEIC_ACID_METABOLISM1.5180.0310.139
c5.bp.v7.1.symbols.gmtGO_MRNA_SPLICE_SITE_SELECTION1.9350.0010.133
GO_HISTONE_H3_K27_METHYLATION1.8930.0010.133
GO_EXTRACELLULAR_TRANSPORT1.8710.0010.133

NES: normalized enrichment score; FDR: false discovery rate.

Figure 5

(a, b) The combination of gene ASB16 GO and KEGG results. (c, d) The combination of gene NEDD4 GO and KEGG results.

4. Discussion

Lung cancer, as a malignant tumor with high morbidity and mortality in the world, is not only difficult to determine the cause of the disease but also has a poor survival rate. LUAD is the most common pathological classification of lung cancer, so it is of great research value to improve the survival rate of LUAD. The previously identified genes associated with lung cancer and LUAD survival are located mainly on chromosome 6. The enrichment analysis of these genes showed that the molecular function was mainly to selectively and noncovalently interact with the same protein or protein, and the biological process was mainly a process of activating or increasing the transcription frequency, rate, or degree of RNA polymerase II promoter. The component composition mainly included the integral component of the membrane. In recent years, studies on the survival rate of patients with LUAD have mostly focused on the prediction of genes related to prognosis, the manipulation of the immune system in the treatment of LUAD [6], the study of smoking and the occurrence of LUAD, and the use of SNP to predict the prognosis of LUAD. This study is intended to use the new model to screen the prognostic genes associated with LUAD. The resulrs showed that the two genes were associated with prognosis of LUAD and predictive genes were selected by linear mixed model and Cox regression model. Due to too many screened genes, there was excessive analysis of biological functional analysis of signaling pathways. Therefore, we use the MCODE plugin to connect many genes with a number of genes extracted and then to separate biology related analysis. Gene NEDD4 also enriched in multiple pathways. Previous studies have found that the loci associated with LUAD are mostly located on chromosome 5, 6, 15, and 17. In this study, the genes were ASB16 (17q21.31) and NEDD4 (15q21.3). The protein encoded by ASB16 gene is a member of the protein family which contains the SOCS box-containing (ASB) and the repeated sequence of anchor proteins. They contain the repeat sequences of anchored protein and the SOCS box domains. Ankyrin repeat sequence is a kind of protein sequences widely existing in the organism of the dead body. The NEDD4 gene is a founding member of the HECT ubiquitin ligase NEDD4 family, which plays a role in the protein-degrading ubiquitin proteasome system. According to a new study, the important role of the ubiquitin-proteasome system also is after it is make full use of, can metabolic toxins such as garbage, fat, and cancer cells; the human body; and metabolic energy can stimulate cell reproducing itself in order to complete the self-metabolism of the human body repair function. In this study, we identified two prognostic genes associated with LUAD survival, and it provided a basis for improving the survival rate of LUAD. Although the gene ASB18 has not been determined to be associated with the prognosis of LUAD, it has been shown that it is related to smoking. Smoking is an environmental risk factor for LUAD,which can be further studied.

5. Conclusion

Our study identified several genes that may be associated with the survival of lung adenocarcinoma, in particular two new genes (ASB16, NEDD4)) that provide evidence for the prognosis of lung adenocarcinoma, and further studies are needed to confirm our findings.
  39 in total

1.  Genome-wide association study confirms lung cancer susceptibility loci on chromosomes 5p15 and 15q25 in an African-American population.

Authors:  Krista A Zanetti; Zhaoming Wang; Melinda Aldrich; Christopher I Amos; William J Blot; Elise D Bowman; Laurie Burdette; Qiuyin Cai; Neil Caporaso; Charles C Chung; Elizabeth M Gillanders; Christopher A Haiman; Helen M Hansen; Brian E Henderson; Laurence N Kolonel; Loic Le Marchand; Shengchao Li; Lorna Haughton McNeill; Bríd M Ryan; Ann G Schwartz; Jennette D Sison; Margaret R Spitz; Margaret Tucker; Angela S Wenzlaff; John K Wiencke; Lynne Wilkens; Margaret R Wrensch; Xifeng Wu; Wei Zheng; Weiyin Zhou; David Christiani; Julie R Palmer; Trevor M Penning; Alyssa G Rieber; Lynn Rosenberg; Edward A Ruiz-Narvaez; Li Su; Anil Vachani; Yongyue Wei; Alexander S Whitehead; Stephen J Chanock; Curtis C Harris
Journal:  Lung Cancer       Date:  2016-05-13       Impact factor: 5.705

2.  A genome-wide association study identifies two new lung cancer susceptibility loci at 13q12.12 and 22q12.2 in Han Chinese.

Authors:  Zhibin Hu; Chen Wu; Yongyong Shi; Huan Guo; Xueying Zhao; Zhihua Yin; Lei Yang; Juncheng Dai; Lingmin Hu; Wen Tan; Zhiqiang Li; Qifei Deng; Jiucun Wang; Wei Wu; Guangfu Jin; Yue Jiang; Dianke Yu; Guoquan Zhou; Hongyan Chen; Peng Guan; Yijiang Chen; Yongqian Shu; Lin Xu; Xiangyang Liu; Li Liu; Ping Xu; Baohui Han; Chunxue Bai; Yuxia Zhao; Haibo Zhang; Ying Yan; Hongxia Ma; Jiaping Chen; Mingjie Chu; Feng Lu; Zhengdong Zhang; Feng Chen; Xinru Wang; Li Jin; Jiachun Lu; Baosen Zhou; Daru Lu; Tangchun Wu; Dongxin Lin; Hongbing Shen
Journal:  Nat Genet       Date:  2011-07-03       Impact factor: 38.330

3.  The 18p11.22 locus is associated with never smoker non-small cell lung cancer susceptibility in Korean populations.

Authors:  Myung-Ju Ahn; Hong-Hee Won; Jeeyun Lee; Seung-Tae Lee; Jong-Mu Sun; Yeon Hee Park; Jin Seok Ahn; O Jung Kwon; Hojoong Kim; Young Mog Shim; Jhingook Kim; Kwhanmien Kim; Yeul Hong Kim; Jae Yong Park; Jong-Won Kim; Keunchil Park
Journal:  Hum Genet       Date:  2011-08-25       Impact factor: 4.132

4.  Genome-wide association analysis identifies new lung cancer susceptibility loci in never-smoking women in Asia.

Authors:  Qing Lan; Chao A Hsiung; Keitaro Matsuo; Yun-Chul Hong; Adeline Seow; Zhaoming Wang; H Dean Hosgood; Kexin Chen; Jiu-Cun Wang; Nilanjan Chatterjee; Wei Hu; Maria Pik Wong; Wei Zheng; Neil Caporaso; Jae Yong Park; Chien-Jen Chen; Yeul Hong Kim; Young Tae Kim; Maria Teresa Landi; Hongbing Shen; Charles Lawrence; Laurie Burdett; Meredith Yeager; Jeffrey Yuenger; Kevin B Jacobs; I-Shou Chang; Tetsuya Mitsudomi; Hee Nam Kim; Gee-Chen Chang; Bryan A Bassig; Margaret Tucker; Fusheng Wei; Zhihua Yin; Chen Wu; She-Juan An; Biyun Qian; Victor Ho Fun Lee; Daru Lu; Jianjun Liu; Hyo-Sung Jeon; Chin-Fu Hsiao; Jae Sook Sung; Jin Hee Kim; Yu-Tang Gao; Ying-Huang Tsai; Yoo Jin Jung; Huan Guo; Zhibin Hu; Amy Hutchinson; Wen-Chang Wang; Robert Klein; Charles C Chung; In-Jae Oh; Kuan-Yu Chen; Sonja I Berndt; Xingzhou He; Wei Wu; Jiang Chang; Xu-Chao Zhang; Ming-Shyan Huang; Hong Zheng; Junwen Wang; Xueying Zhao; Yuqing Li; Jin Eun Choi; Wu-Chou Su; Kyong Hwa Park; Sook Whan Sung; Xiao-Ou Shu; Yuh-Min Chen; Li Liu; Chang Hyun Kang; Lingmin Hu; Chung-Hsing Chen; William Pao; Young-Chul Kim; Tsung-Ying Yang; Jun Xu; Peng Guan; Wen Tan; Jian Su; Chih-Liang Wang; Haixin Li; Alan Dart Loon Sihoe; Zhenhong Zhao; Ying Chen; Yi Young Choi; Jen-Yu Hung; Jun Suk Kim; Ho-Il Yoon; Qiuyin Cai; Chien-Chung Lin; In Kyu Park; Ping Xu; Jing Dong; Christopher Kim; Qincheng He; Reury-Perng Perng; Takashi Kohno; Sun-Seog Kweon; Chih-Yi Chen; Roel Vermeulen; Junjie Wu; Wei-Yen Lim; Kun-Chieh Chen; Wong-Ho Chow; Bu-Tian Ji; John K C Chan; Minjie Chu; Yao-Jen Li; Jun Yokota; Jihua Li; Hongyan Chen; Yong-Bing Xiang; Chong-Jen Yu; Hideo Kunitoh; Guoping Wu; Li Jin; Yen-Li Lo; Kouya Shiraishi; Ying-Hsiang Chen; Hsien-Chih Lin; Tangchun Wu; Yi-Long Wu; Pan-Chyr Yang; Baosen Zhou; Min-Ho Shin; Joseph F Fraumeni; Dongxin Lin; Stephen J Chanock; Nathaniel Rothman
Journal:  Nat Genet       Date:  2012-11-11       Impact factor: 38.330

5.  Lung cancer in never-smokers - what are the differences?

Authors:  Margarida Dias; Rita Linhas; Sérgio Campainha; Sara Conde; Ana Barroso
Journal:  Acta Oncol       Date:  2017-02-17       Impact factor: 4.089

6.  A genome-wide gene-gene interaction analysis identifies an epistatic gene pair for lung cancer susceptibility in Han Chinese.

Authors:  Minjie Chu; Ruyang Zhang; Yang Zhao; Chen Wu; Huan Guo; Baosen Zhou; Jiachun Lu; Yongyong Shi; Juncheng Dai; Guangfu Jin; Hongxia Ma; Jing Dong; Yongyue Wei; Cheng Wang; Jianhang Gong; Chongqi Sun; Meng Zhu; Yongyong Qiu; Tangchun Wu; Zhibin Hu; Dongxin Lin; Hongbing Shen; Feng Chen
Journal:  Carcinogenesis       Date:  2013-12-09       Impact factor: 4.944

7.  A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25.

Authors:  Rayjean J Hung; James D McKay; Valerie Gaborieau; Paolo Boffetta; Mia Hashibe; David Zaridze; Anush Mukeria; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Chu Chen; Gary Goodman; John K Field; Triantafillos Liloglou; George Xinarianos; Adrian Cassidy; John McLaughlin; Geoffrey Liu; Steven Narod; Hans E Krokan; Frank Skorpen; Maiken Bratt Elvestad; Kristian Hveem; Lars Vatten; Jakob Linseisen; Françoise Clavel-Chapelon; Paolo Vineis; H Bas Bueno-de-Mesquita; Eiliv Lund; Carmen Martinez; Sheila Bingham; Torgny Rasmuson; Pierre Hainaut; Elio Riboli; Wolfgang Ahrens; Simone Benhamou; Pagona Lagiou; Dimitrios Trichopoulos; Ivana Holcátová; Franco Merletti; Kristina Kjaerheim; Antonio Agudo; Gary Macfarlane; Renato Talamini; Lorenzo Simonato; Ray Lowry; David I Conway; Ariana Znaor; Claire Healy; Diana Zelenika; Anne Boland; Marc Delepine; Mario Foglio; Doris Lechner; Fumihiko Matsuda; Helene Blanche; Ivo Gut; Simon Heath; Mark Lathrop; Paul Brennan
Journal:  Nature       Date:  2008-04-03       Impact factor: 49.962

8.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.

Authors:  Freddie Bray; Jacques Ferlay; Isabelle Soerjomataram; Rebecca L Siegel; Lindsey A Torre; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-09-12       Impact factor: 508.702

9.  Identification of susceptibility pathways for the role of chromosome 15q25.1 in modifying lung cancer risk.

Authors:  Xuemei Ji; Yohan Bossé; Maria Teresa Landi; Jiang Gui; Xiangjun Xiao; David Qian; Philippe Joubert; Maxime Lamontagne; Yafang Li; Ivan Gorlov; Mariella de Biasi; Younghun Han; Olga Gorlova; Rayjean J Hung; Xifeng Wu; James McKay; Xuchen Zong; Robert Carreras-Torres; David C Christiani; Neil Caporaso; Mattias Johansson; Geoffrey Liu; Stig E Bojesen; Loic Le Marchand; Demetrios Albanes; Heike Bickeböller; Melinda C Aldrich; William S Bush; Adonina Tardon; Gad Rennert; Chu Chen; M Dawn Teare; John K Field; Lambertus A Kiemeney; Philip Lazarus; Aage Haugen; Stephen Lam; Matthew B Schabath; Angeline S Andrew; Hongbing Shen; Yun-Chul Hong; Jian-Min Yuan; Pier A Bertazzi; Angela C Pesatori; Yuanqing Ye; Nancy Diao; Li Su; Ruyang Zhang; Yonathan Brhane; Natasha Leighl; Jakob S Johansen; Anders Mellemgaard; Walid Saliba; Christopher Haiman; Lynne Wilkens; Ana Fernandez-Somoano; Guillermo Fernandez-Tardon; Erik H F M van der Heijden; Jin Hee Kim; Juncheng Dai; Zhibin Hu; Michael P A Davies; Michael W Marcus; Hans Brunnström; Jonas Manjer; Olle Melander; David C Muller; Kim Overvad; Antonia Trichopoulou; Rosario Tumino; Jennifer Doherty; Gary E Goodman; Angela Cox; Fiona Taylor; Penella Woll; Irene Brüske; Judith Manz; Thomas Muley; Angela Risch; Albert Rosenberger; Kjell Grankvist; Mikael Johansson; Frances Shepherd; Ming-Sound Tsao; Susanne M Arnold; Eric B Haura; Ciprian Bolca; Ivana Holcatova; Vladimir Janout; Milica Kontic; Jolanta Lissowska; Anush Mukeria; Simona Ognjanovic; Tadeusz M Orlowski; Ghislaine Scelo; Beata Swiatkowska; David Zaridze; Per Bakke; Vidar Skaug; Shanbeh Zienolddiny; Eric J Duell; Lesley M Butler; Woon-Puay Koh; Yu-Tang Gao; Richard Houlston; John McLaughlin; Victoria Stevens; David C Nickle; Ma'en Obeidat; Wim Timens; Bin Zhu; Lei Song; María Soler Artigas; Martin D Tobin; Louise V Wain; Fangyi Gu; Jinyoung Byun; Ahsan Kamal; Dakai Zhu; Rachel F Tyndale; Wei-Qi Wei; Stephen Chanock; Paul Brennan; Christopher I Amos
Journal:  Nat Commun       Date:  2018-08-13       Impact factor: 14.919

10.  Integrative analysis of DNA methylation-driven genes for the prognosis of lung squamous cell carcinoma using MethylMix.

Authors:  Rui Li; Yun-Hong Yin; Jia Jin; Xiao Liu; Meng-Yu Zhang; Yi-E Yang; Yi-Qing Qu
Journal:  Int J Med Sci       Date:  2020-03-05       Impact factor: 3.738

View more
  1 in total

1.  Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma.

Authors:  Liping Lin; Xuan Wu; Yuanxue Jiang; Caijiu Deng; Xi Luo; Jianjun Han; Jiazhu Hu; Xiaolong Cao
Journal:  PeerJ       Date:  2022-05-24       Impact factor: 3.061

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.